ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALGS Aligos Therapeutics Inc

0.846
0.00 (0.00%)
Pre Market
Last Updated: 03:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aligos Therapeutics Inc ALGS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.846 03:00:00
Open Price Low Price High Price Close Price Previous Close
0.846
more quote information »

Recent News

Date Time Source Heading
4/30/202415:05GLOBEAligos Therapeutics to Announce 1st Quarter 2024 Financial..
4/25/202415:05GLOBEAligos Therapeutics Presents Positive Clinical Data at..
4/25/202407:00GLOBEAligos Therapeutics Mourns the Passing of MASH Industry..
4/09/202407:00GLOBEAligos Therapeutics to Participate in the Piper Sandler..
4/03/202407:00GLOBEAligos Therapeutics Announces First Subjects Dosed in the..
3/27/202407:00GLOBEAligos Therapeutics Presents Positive Clinical Data at APASL..
3/18/202407:00GLOBEAligos Therapeutics Announces the Initiation of the Phase 2a..
3/12/202415:05GLOBEAligos Therapeutics Reports Recent Business Progress..
3/05/202415:05GLOBEAligos Therapeutics to Announce 4th Quarter 2023 Financial..
3/04/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202407:00GLOBEAligos Therapeutics To Participate in the Leerink Partners..
2/20/202407:00GLOBEAligos Therapeutics to Host KOL Event to Discuss Phase 2a..
2/13/202407:00GLOBEAligos Therapeutics Strengthens Finance Leadership Team with..
1/30/202406:04EDGAR2Form SC TO-I - Tender offer statement by Issuer
1/25/202405:12EDGAR2Form SC TO-C - Written communication relating to an issuer..
1/25/202405:06EDGAR2Form 8-K - Current report
11/28/202315:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/22/202315:05EDGAR2Form 8-K - Current report
11/17/202315:38EDGAR2Form S-3 - Registration statement under Securities Act of..
11/15/202315:01EDGAR2Form 8-K - Current report
11/07/202311:03EDGAR2Form D - Notice of Exempt Offering of Securities
11/02/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/02/202315:05EDGAR2Form 8-K - Current report
10/25/202316:05EDGAR2Form 8-K - Current report
10/18/202307:45EDGAR2Form 8-K - Current report
9/12/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202315:01EDGAR2Form 8-K - Current report
8/03/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:05EDGAR2Form 8-K - Current report
8/01/202315:52EDGAR2Form 8-K - Current report
7/25/202315:02EDGAR2Form 8-K - Current report
7/21/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock